BioMerieux Recalls Etest Benzyl Penicillin Strips Due to Stability Issues
BioMerieux SA is recalling Etest Benzyl Penicillin PG256 FOAM packaging because shelf-life claims are not supported by internal testing.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the hazard is a documentation/stability issue (unsupported shelf-life claims) rather than a direct physical defect or reported injury, fitting the 'Moderate' criteria for minor labeling or documentation issues.
Plain-English summary
BioMerieux SA is recalling Etest Benzyl Penicillin PG256 FOAM packaging, a quantitative technique used to determine the antimicrobial susceptibility of various bacteria. The recall is due to product stability issues, specifically that the current shelf-life claims for these products are not supported by internal testing.
The affected products include Etest Benzylpenicillin PG 0.016-256 (high) with Reference no. 502558 and Reference no. 502518. Specific lot numbers are listed in the recall documentation. The products were distributed worldwide, including nationwide in the United States and in numerous foreign countries.
Users of these medical devices should stop using the affected lots and contact BioMerieux SA for further instructions or a replacement. This recall is classified as Class II by the FDA, indicating a reasonable probability that the use of the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- ETEST Benzyl Penicillin PG256 FOAM packaging, Product Name: Etest Benzylpenicillin PG 0.016-256 (high). ETEST is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria such as Enterobacteriaceae…
- Manufacturer
- BioMerieux SA
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Reference no. 502558
- Lot #1003036730
- 1003142000
- 1003191650
- 1003408580
- 1004047410
- 1004139950
- 1004242300
- 1004539350
- 1004783810
- 1004872380
- 1004910650 & 1004985540 and Reference no. 502518
- Lot #1002911350
- 1002964350
- 1003012790
- 1004047370
- 1004140000
- 1004244180
- 1004420440
- 1004539950
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 12 recalled by BioMerieux SA under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · BioMerieux SA
See all →- HighMYLA Diagnostic System Software Versions Recalled for Risk of False Negatives
FDA (Devices) · 2021-10-20
- HighMYLA Laboratory Software: Potential Test Result Alteration from Software Anomaly
FDA (Devices) · 2021-08-18
- ModerateBioMerieux NucliSENS Magnetic Extraction Reagents Recalled Due to Temperature Exposure
FDA (Devices) · 2018-10-31
- ModerateBioMerieux Recalls VIDAS FSH Assay Kits Due to Calibration Issues
FDA (Devices) · 2018-07-04
- ModerateBioMérieux Recalls VITEK 2 Gram-Positive Cards Due to Temperature Excursion
FDA (Devices) · 2018-06-20
Same hazard · stability
See all →- ModeratePhilips DigitalDiagnost C90 delivered without required wall stand seismic kit
FDA (Devices) · 2026-06-17
- ModerateAlbuterol inhalers recalled after failing stability specification for particle size distribution
FDA (Drugs) · 2025-08-27
- ModerateHemoCue glucose microcuvettes experienced transit time outside of specified limits
FDA (Devices) · 2025-07-09
- ModerateApollo Care Recalls Vancomycin IV Bags Due to Unsupported Expiry Date
FDA (Drugs) · 2018-04-04
- SevereApollo Care Recalls Vancomycin IV Bags Due to Unsupported Expiry Date
FDA (Drugs) · 2018-03-14
Similar recalls
- ModerateBioMerieux ETEST XM256 Cefuroxime Recalled for Potential Performance Issues
FDA (Devices) · 2017-03-01
- ModerateBioMerieux Recalls Ceftriaxone ETEST Kits Due to Performance Issues
FDA (Devices) · 2017-05-31
- CriticalBiomerieux Etest PIP/TAZO/CON-4 PTC 256 Recalled for Erroneous Results
FDA (Devices) · 2015-12-30
- SevereBiomerieux Recalls Etest PIP/TAZO/CON-4 PTC 256 Antimicrobial Susceptibility Tests
FDA (Devices) · 2015-12-30
- HighBioMerieux Recalls ETEST ETP32 Ertapenem Strips Due to False Results
FDA (Devices) · 2017-05-24
- ModerateFDA Recalls ETEST Clinical Benzylpenicil Test Due to Storage Excursion
FDA (Devices) · 2023-01-11